Researchers conclude that EnChroma's glasses do not improve results of color-blind participants

In Europe, 8% of the male population and 0.5% of the female population (that is, almost 22 million persons in the EU) present a congenital anomaly in their color vision, commonly known as color-blindness. To date, no effective treatment for color-blindness has been found, although genetic therapies have been successfully tested on mice and primates.

Currently, there are various 'active' and 'passive' aids on the market that claim to improve color-defective vision among color-blind people, some of which are of dubious help. So-called 'active' aids modify the color of images by using image-processing algorithms to increase the contrast between colors that, otherwise, would be indistinguishable for the user. 'Passive' aids are based on color filters that can even be used as tinted glasses or contact lenses, even with their corresponding optometric compensation. Among the passive aids on the market, the glasses marketed by the US companies EnChroma and VINO are particularly noteworthy for their novelty and media profile.

In 2018, researchers at the University of Granada (UGR) analyzed the performance of EnChroma's glasses (model Cx-65), concluding that they do not improve the results of color-blind participants in a series of diagnostic tests. Nor did they enable the color-blind participants to enjoy color vision that resembled that of normal observers. The published conclusions of this research had major social repercussions.

Subsequently, the UGR researchers turned to analyzing some of the viral videos made about the O2Amp 'Oxy-Iso' glasses. In these videos, color-blind users can be seen crying with joy when using the product for the first time. Having studied VINO's advertising claims for such products, the UGR scientists decided to undertake a meticulous study of the effectiveness of these glasses. Their investigative work was driven by a strong conviction that scientists hold a moral contract with society that calls on them to identify and refute—on the basis of rigorous experiments—any erroneous information that companies disseminate. In this case, the information that these companies have targeted at color-blind people could generate false hopes, such as the suggestion that the product would enable users to see new colors or even to correct their color-blindness altogether.

Although VINO Optics' O2Amp 'Oxy-Iso' glasses were initially developed for medical professionals to improve the contrast of the veins under the skin, the inventors claim their technology helps color-blind people with red-green deficiency (known as deutans and protans). On its website, the company currently (June 2019) states: "Our Color Blindness technology corrects red-green color deficiency, based on a scientific understanding of what color vision is for." It also claims their technology "does more than simply allow you to pass the Ishihara test," which is one of the classic, and basic, tests for identifying whether a person is color-blind.

The researchers followed a dual strategy to assess the efficiency of these glasses. First, they evaluated the vision of 52 color-blind people, with and without the VINO glasses by means of different tests typically used to assess color vision: the aforementioned Ishihara color test (recognition test) and the Farnsworth-Munsell (FM) 100 hue test (arrangement test). They also added a color-naming test based on the X-Rite color chart. The second strategy was to simulate the effect of the glasses, using the spectral transmittance of the VINO lenses, on observers who presented different degrees of simulated color-blindness. This enabled the team to assess the changes they produced in the appearance of colors, as perceived by different subjects. The researchers completed their study by comparing the results with those obtained by the EnChroma Cx-65 glasses.

The low-level transmittance of the VINO O2Amp 'Oxy-Iso' glasses in the intermediate region of the spectrum produced a significant change in the appearance of the color, especially in the chroma attribute. This change allows some color-blind subjects, particularly deutans, to pass simple recognition tests, such as the Ishihara, but not the more comprehensive arrangement tests, such as the FM100. These results, together with those obtained by means of simulation using a novel "Daltonization" algorithm, showed that these glasses do not improve the color vision of color-blind subjects to the extent that they can see color as people with normal vision. However, they may facilitate some tasks requiring color discrimination. In fact, these glasses can particularly aid deutans in some tasks, such as helping them to distinguish some colors that can cause confusion (at the risk of confusing others that they previously perceived differently). In addition, the glasses can be useful in some specific applications (such as improving the contrast of veins under the skin), as is the case with other color filters used in activities such as hunting or shooting, or in low-vision contexts.

In a paper recently published in the journal Optics Express(one of the most widely-respected publications in the optics field, with among the highest impact indices), the UGR researchers conclude: "Our results support the hypothesis that glasses with filters are unable to effectively resolve the problems related to color vision deficiency."

Despite the efforts of this research team, there remain numerous alternatives on the market that are based on the use of colored filters. These, too, use similar marketing strategies to promote their products, based on the idea of ​​achieving normal color vision among color-blind subjects.

The research group at the UGR's Department of Optics (Faculty of Science) comprises doctors Miguel ángel Martínez Domingo, Luis Gómez Robledo, Eva Valero Benito, Rafael Huertas Roa, Javier Hernández Andrés and Enrique Hita Villaverde and student Silvia Ezpeleta Gascón.

Source:
Journal reference:

Miguel, A. et al. (2019) Assessment of VINO filters for correcting red-green Color Vision Deficiency. Optics Express. doi.org/10.1364/OE.27.017954.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Children's Tumor Foundation harnesses interest in rare disease research through NF Innovation Week